INIS
nervous system diseases
100%
patients
98%
risks
87%
genes
82%
brain
77%
dna
69%
methylation
55%
genetics
53%
mice
51%
levels
48%
therapy
46%
control
45%
psychoses
37%
reviews
33%
populations
32%
kynurenine
32%
interactions
28%
neurons
28%
liabilities
28%
humans
27%
diseases
25%
symptoms
25%
comparative evaluations
21%
adults
21%
regulations
20%
blood
20%
nuclei
20%
offsprings
19%
plasticity
19%
psychological behavior
19%
phenotype
19%
tryptophan
19%
stem cells
19%
glucocorticoids
19%
animals
18%
receptors
18%
aging
17%
assessments
16%
trauma
15%
genotype
15%
hippocampus
15%
values
15%
pathology
14%
messenger-rna
14%
antidepressants
14%
females
14%
modeling
14%
males
14%
data
14%
pain
13%
design
13%
prediction
13%
mental disorders
13%
serotonin
13%
methyl transferases
12%
correlations
11%
environment
11%
modifications
11%
in vitro
10%
cerebrospinal fluid
10%
validation
10%
sex
10%
hearings
9%
tools
9%
biological markers
9%
disturbances
9%
molecules
9%
rodents
9%
rna
8%
environmental exposure
8%
histones
8%
transcription
8%
plasma
8%
pathogenesis
8%
spectra
8%
dimensions
8%
length
7%
inflammation
7%
metabolites
7%
lifetime
7%
datasets
7%
metabolic pathways
7%
morphology
7%
surgery
7%
tissues
6%
performance
6%
losses
6%
speech
6%
carbon dioxide
6%
capture
6%
lasers
6%
hemoglobin
6%
lipopolysaccharides
6%
superoxide dismutase
6%
dilution
6%
computers
6%
cations
6%
algorithms
6%
growth factors
6%
mineralocorticoids
6%
Keyphrases
Schizophrenia
72%
Alzheimer's Disease
41%
Electroconvulsive Therapy
31%
Posttraumatic Stress Disorder
31%
Psychosis
28%
DNA Methylation (DNAm)
26%
Kynurenine
25%
Polygenic Risk Score
23%
Tryptophan
23%
Kynurenine Pathway
22%
Meta-analysis
21%
Exposome
20%
5-hydroxymethylcytosine (5hmC)
19%
Fluoxetine
19%
Healthy Controls
17%
Quinolinic Acid
17%
Neuroplasticity
16%
Epigenetic Regulation
16%
Genetic Liability
15%
Hippocampus
15%
Pathophysiology
15%
Mental Health
15%
Polygenic Risk
15%
Epigenetic Mechanisms
15%
Brain-derived Neurotrophic Factor
14%
Genotype
14%
MicroRNA
14%
Sibling Controls
14%
Alzheimer's Disease Pathology
13%
Antidepressants
13%
Physical Health
13%
Genetic Risk
13%
SH-SY5Y Cells
13%
Parkinson's Disease
13%
Cerebrospinal Fluid
13%
Facial Emotion Recognition
12%
Chronic Postsurgical Pain
12%
Control Results
12%
Genetic Polymorphism
12%
Molecular Genetics
12%
Induced Pluripotent Stem Cells (iPSCs)
12%
Mouse Brain
12%
Epigenetics
12%
Kynurenic Acid
11%
MRNA Expression
10%
Prenatal Stress
10%
Clinical High Risk for Psychosis (CHR-P)
10%
Selective Serotonin Reuptake Inhibitors
10%
Psychotic Disorders
10%
Cognitive Impairment
10%
Environmental Risk
9%
Mild Cognitive Impairment
9%
Mental Disorders
9%
Cannabis Use
9%
Immune System
9%
Cognitive Functioning
9%
Neuronal Cells
9%
Stress Disorders
9%
Epigenetic Dysregulation
9%
Gene-environment Interaction
9%
Cognitive Decline
9%
Glucocorticoid Receptor
9%
TrkB
9%
Kynurenine Pathway Metabolites
8%
Alzheimer's Dementia
8%
Transdiagnostic
8%
Depression Treatment
8%
Depressive-like Behavior
8%
Molecular Mechanism
8%
Metabolic Pathway
8%
Transcriptomics
8%
Immunoreactivity
8%
Gene Expression
8%
Jumping to Conclusions Bias
7%
Intermediate Phenotype
7%
Epigenetic Effects
7%
Delusional Ideation
7%
Age-related
7%
Major Depressive Disorder
7%
Patients with Cognitive Impairments
7%
Environmental Exposure
7%
Psychiatric Disorders
7%
Human Neurons
7%
Parkinson Patients
7%
Stress-related Mental Disorders
7%
Rodents
7%
Nucleus Accumbens
7%
Carbon Dioxide
7%
Disease-specific
7%
Disease-associated
7%
Episodic Memory
7%
Blood Levels
7%
Male Offspring
7%
Neurotrophic Factors
7%
Early-life Exposure
7%
Epigenetic Modification
7%
Methylation
7%
Methylome
7%
Clinical High Risk
7%
Overexpression
7%
Neuroscience
Alzheimer's Disease
57%
DNA Methylation
32%
Electroconvulsive Therapy
31%
Posttraumatic Stress Disorder
30%
Gene Expression
28%
Brain-Derived Neurotrophic Factor
28%
Kynurenine
25%
Meta-Analysis
25%
Cannabis
22%
Behavior (Neuroscience)
21%
Cognitive Disorders
21%
Parkinson's Disease
20%
Mental Disorder
19%
MicroRNA
19%
Fluoxetine
19%
Schizophrenia Spectrum Disorder
19%
Hippocampus
17%
Neuroplasticity
17%
Messenger RNA
15%
5-Methylcytosine
15%
5-Hydroxymethylcytosine
14%
Antidepressant
14%
Major Depressive Disorder
12%
DNA Methyltransferase 3A
12%
Glucocorticoid Receptor
12%
Mouse Brain
12%
Tryptophan
12%
In Vitro
12%
Selective Serotonin Reuptake Inhibitor
12%
Quinolinic Acid
11%
Prenatal Stress
11%
Panic Disorder
11%
Neurotrophin
9%
Mild Cognitive Impairment
9%
Treatment of Depression
8%
Epigenetics
8%
Episodic Memory
7%
Stem Cell
7%
Blood Plasma
7%
Nucleus Accumbens
7%
Epigenetic Mechanism
7%
Neurotrophic Factor
7%
Methylation
7%
Metabolic Pathway
7%
Social Defeat
6%
Glucocorticoid
6%
Neurodegeneration
6%
Treatment-Resistant Schizophrenia
6%
Genetic Polymorphism
6%
Dentate Gyrus
6%
Growth Factor
6%
Exposure Therapy
6%
Tinnitus
6%
Brainstem
6%
Histone Deacetylase
6%
Neural Stem Cell
6%
Neuroticism
6%
Ménière Disease
6%
Sensation of Hearing
6%
Agomelatine
6%
DNA Methyltransferase
6%
Behavioral Despair
6%
Polyinosinic:polycytidylic Acid
6%
Agoraphobia
6%
Functional Magnetic Resonance Imaging
6%
Epigenetic Modification
6%
Purkinje Cell
6%
Copper Zinc Superoxide Dismutase
6%
Amiloride
6%
Cerebrovascular Accident
6%
Transcranial Magnetic Stimulation
6%
Social Cognition
6%
Working Memory
6%
Mineralocorticoid Receptor
6%
Genetic Transcription
6%
Cognitive Function
6%
Cation Channel
6%
Drug Therapy
6%
Kynurenic Acid
5%